Cisplatin Nanoparticles Promote Intratumoral CD8+ T Cell Priming via Antigen Presentation and T Cell Receptor Crosstalk
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cisplatin Nanoparticles Promote Intratumoral CD8+ T Cell Priming via Antigen Presentation and T Cell Receptor Crosstalk
Authors
Keywords
-
Journal
NANO LETTERS
Volume 22, Issue 8, Pages 3328-3339
Publisher
American Chemical Society (ACS)
Online
2022-04-12
DOI
10.1021/acs.nanolett.2c00478
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination
- (2021) Jiali Yu et al. NATURE MEDICINE
- Host response to immune checkpoint inhibitors contributes to tumor aggressiveness
- (2021) Irina Khononov et al. Journal for ImmunoTherapy of Cancer
- MBene as a Theranostic Nanoplatform for Photocontrolled Intratumoral Retention and Drug Release
- (2021) Danyang Chen et al. ADVANCED MATERIALS
- Fabricating nanoparticles co-loaded with survivin siRNA and Pt(IV) prodrug for the treatment of platinum-resistant lung cancer
- (2021) Shuting Ma et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Cisplatin nanoparticles possess stronger anti-tumor synergy with PD1/PD-L1 inhibitors than the parental drug
- (2021) Na Shen et al. Acta Biomaterialia
- Tumor-Associated-Macrophage-Membrane-Coated Nanoparticles for Improved Photodynamic Immunotherapy
- (2021) Cailing Chen et al. NANO LETTERS
- Critical role of the CD44lowCD62Llow CD8+ T cell subset in restoring antitumor immunity in aged mice
- (2021) Yuka Nakajima et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gold Nanorods Exhibit Intrinsic Therapeutic Activity via Controlling N6-Methyladenosine-Based Epitranscriptomics in Acute Myeloid Leukemia
- (2021) Yangyang Du et al. ACS Nano
- Hepcidin‐Based Nanocomposites for Enhanced Cancer Immunotherapy by Modulating Iron Export‐Mediated N6‐Methyladenosine RNA Transcript
- (2021) Lingxiao Zhang et al. ADVANCED FUNCTIONAL MATERIALS
- The entry of nanoparticles into solid tumours
- (2020) Shrey Sindhwani et al. NATURE MATERIALS
- Molecularly Imprinted Polymer Nanoparticles: An Emerging Versatile Platform for Cancer Therapy
- (2020) Shuxin Xu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Noncanonical binding of Lck to CD3ε promotes TCR signaling and CAR function
- (2020) Frederike A. Hartl et al. NATURE IMMUNOLOGY
- Cellular Interactions of Liposomes and PISA Nanoparticles during Human Blood Flow in a Microvascular Network
- (2020) Mai N. Vu et al. Small
- T-cell agonists in cancer immunotherapy
- (2020) Yeonjoo Choi et al. Journal for ImmunoTherapy of Cancer
- Precise delivery of obeticholic acid via nanoapproach for triggering natural killer T cell-mediated liver cancer immunotherapy
- (2020) Guofeng Ji et al. Acta Pharmaceutica Sinica B
- Carrier‐Free Platinum Nanomedicine for Targeted Cancer Therapy
- (2020) Changping Wang et al. Small
- Store-Operated Calcium Entry Contributes to Cisplatin-Induced Cell Death in Non-Small Cell Lung Carcinoma
- (2019) Roberta Gualdani et al. Cancers
- Modulation of temozolomide dose differentially affects T-cell response to immune checkpoint inhibition
- (2019) Aida Karachi et al. NEURO-ONCOLOGY
- Mechano-regulation of Peptide-MHC Class I Conformations Determines TCR Antigen Recognition
- (2019) Peng Wu et al. MOLECULAR CELL
- Immune cell therapy for hepatocellular carcinoma
- (2019) Eishiro Mizukoshi et al. Journal of Hematology & Oncology
- Recent progress in nanotechnology-based novel drug delivery systems in designing of cisplatin for cancer therapy: an overview
- (2019) Muhammad Asim Farooq et al. Artificial Cells Nanomedicine and Biotechnology
- Near-Infrared Photoimmunotherapy of Cancer
- (2019) Hisataka Kobayashi et al. ACCOUNTS OF CHEMICAL RESEARCH
- Analysis of the Relationship Between the Degree of Dysbiosis in Gut Microbiota and Prognosis at Different Stages of Primary Hepatocellular Carcinoma
- (2019) Jiajia Ni et al. Frontiers in Microbiology
- Salinomycin reduces growth, proliferation and metastasis of cisplatin resistant breast cancer cells via NF-kB deregulation
- (2019) Mrityunjay Tyagi et al. TOXICOLOGY IN VITRO
- Regulation of the Cell Biology of Antigen Cross-Presentation
- (2018) J. Magarian Blander Annual Review of Immunology
- Analytical Validation of a Next-Generation Sequencing Assay to Monitor Immune Responses in Solid Tumors
- (2018) Jeffrey M. Conroy et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Cisplatin-DNA adduct repair of transcribed genes is controlled by two circadian programs in mouse tissues
- (2018) Yanyan Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TCR Signaling: Mechanisms of Initiation and Propagation
- (2018) Adam H. Courtney et al. TRENDS IN BIOCHEMICAL SCIENCES
- Nanovaccine Incorporated with Hydroxychloroquine Enhances Antigen Cross-Presentation and Promotes Antitumor Immune Responses
- (2018) Jiale Liu et al. ACS Applied Materials & Interfaces
- Evaluation for Synergistic Effects by Combinations of Photodynamic Therapy (PDT) with Temoporfin (mTHPC) and Pt(II) Complexes Carboplatin, Cisplatin or Oxaliplatin in a Set of Five Human Cancer Cell Lines
- (2018) Carsten Lange et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- TAOK3 Regulates Canonical TCR Signaling by Preventing Early SHP-1–Mediated Inactivation of LCK
- (2018) João V. S. Ormonde et al. JOURNAL OF IMMUNOLOGY
- Adoptive immunotherapy combined with FP treatment for head and neck cancer: An in vitro study
- (2017) Mayako Nishio-Nagai et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Resolvins suppress tumor growth and enhance cancer therapy
- (2017) Megan L. Sulciner et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Role of Multiscale Protein Dynamics in Antigen Presentation and T Lymphocyte Recognition
- (2017) R. Charlotte Eccleston et al. Frontiers in Immunology
- Rethinking cancer nanotheranostics
- (2017) Hongmin Chen et al. Nature Reviews Materials
- Assessment of T-cell receptor repertoire and clonal expansion in peripheral T-cell lymphoma using RNA-seq data
- (2017) Qiang Gong et al. Scientific Reports
- Rationale for anti-OX40 cancer immunotherapy
- (2016) Sandrine Aspeslagh et al. EUROPEAN JOURNAL OF CANCER
- Cisplatin Loaded Poly(L-glutamic acid)-g-Methoxy Poly(ethylene glycol) Complex Nanoparticles for Potential Cancer Therapy: Preparation, In Vitro and In Vivo Evaluation
- (2016) Haiyang Yu et al. Journal of Biomedical Nanotechnology
- Balancing efficacy of and host immune responses to cancer therapy: the yin and yang effects
- (2016) Yuval Shaked Nature Reviews Clinical Oncology
- KEGG: new perspectives on genomes, pathways, diseases and drugs
- (2016) Minoru Kanehisa et al. NUCLEIC ACIDS RESEARCH
- Quantitative Proteomic Analysis of Cellular Resistance to the Nanoparticle Abraxane
- (2015) Minzhi Zhao et al. ACS Nano
- Cisplatin-loaded polymeric nanoparticles: Characterization and potential exploitation for the treatment of non-small cell lung carcinoma
- (2015) Chunshan Shi et al. Acta Biomaterialia
- TNF-α produced by SEC2 mutant (SAM-3)-activated human T cells induces apoptosis of HepG2 cells
- (2015) Guojun Zhang et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Host effects contributing to cancer therapy resistance
- (2015) Ofrat Beyar Katz et al. DRUG RESISTANCE UPDATES
- Cisplatin-Induced Antitumor Immunomodulation: A Review of Preclinical and Clinical Evidence
- (2014) A. R. de Biasi et al. CLINICAL CANCER RESEARCH
- A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer
- (2014) Domenica Lorusso et al. GYNECOLOGIC ONCOLOGY
- Nanocarriers for delivery of platinum anticancer drugs
- (2013) Hardeep S. Oberoi et al. ADVANCED DRUG DELIVERY REVIEWS
- OX40 Is a Potent Immune-Stimulating Target in Late-Stage Cancer Patients
- (2013) B. D. Curti et al. CANCER RESEARCH
- Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer
- (2013) L Bracci et al. CELL DEATH AND DIFFERENTIATION
- Paclitaxel-Loaded Polymeric Micelle (230 mg/m2) and Cisplatin (60 mg/m2) vs. Paclitaxel (175 mg/m2) and Cisplatin (60 mg/m2) in Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase IIB Trial
- (2013) Sung Yong Lee et al. Clinical Lung Cancer
- Treatment-induced host-mediated mechanisms reducing the efficacy of antitumor therapies
- (2013) L G M Daenen et al. ONCOGENE
- Defining the Molecular Signature of Chemotherapy-Mediated Lung Tumor Phenotype Modulation and Increased Susceptibility to T-Cell Killing
- (2012) Sofia R. Gameiro et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Tumor-targeted chemotherapy with the nanopolymer-based drug NC-6004 for oral squamous cell carcinoma
- (2012) Kazuhira Endo et al. CANCER SCIENCE
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Chemotherapeutics and Radiation Stimulate MHC Class I Expression through Elevated Interferon-beta Signaling in Breast Cancer Cells
- (2012) Shan Wan et al. PLoS One
- A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours
- (2011) R Plummer et al. BRITISH JOURNAL OF CANCER
- Science gone translational: the OX40 agonist story
- (2011) Andrew D. Weinberg et al. IMMUNOLOGICAL REVIEWS
- Micellization of cisplatin (NC-6004) reduces its ototoxicity in guinea pigs
- (2011) Miyuki Baba et al. JOURNAL OF CONTROLLED RELEASE
- Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release
- (2010) Chris Oerlemans et al. PHARMACEUTICAL RESEARCH
- RNA-Seq gene expression estimation with read mapping uncertainty
- (2009) Bo Li et al. BIOINFORMATICS
- Adoptive Transfer of Human Papillomavirus E7-specific CTL Enhances Tumor Chemoresponse Through the Perforin/Granzyme-mediated Pathway
- (2009) Jeong-Im Sin et al. MOLECULAR THERAPY
- RNA-Seq: a revolutionary tool for transcriptomics
- (2008) Zhong Wang et al. NATURE REVIEWS GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search